NorthX Biologics
NorthX Biologics is a Beyond CDMO with particular strength in the development and manufacture of outer membrane vesicles (OMVs). We support partners from early process development and analytical characterization through to GMP manufacturing and scale-up. NorthX is one of few companies to have scaled an OMV process to 500 L, and we currently manufacture for five different customers in the OMV field. Combining deep process expertise, proven scalability, and regulatory experience, we help innovators move OMV-based vaccines and therapies from concept to clinical and commercial supply.
